All In Biotech

Drug Trial Radar · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

A Phase III Randomised, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity Without Type 2 Diabetes Mellitus (SELENE 1)

Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,500

Planned (sponsor's estimate)

Start

Aug 19, 2026

Primary completion

Aug 11, 2028

Study completion May 21, 2029

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Aug 25, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment

Conditions

  • Obesity or Overweight

Interventions

  • LenbelintideDrug

    IMP injected subcutaneously, once a week. Unit dose strength as per CSP.

  • PlaceboDrug

    Placebo matching IMP dose injected subcutaneously, once a week.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change in body weight from baseline at 68 weeks of treatmentTime frame: 68 weeks

Locations

220 sites in 16 countries. Site status is shown where the registry gives one.

  • Research Site

    Dothan, Alabama · Recruiting

  • Research Site

    Huntsville, Alabama · Not yet recruiting

  • Research Site

    Mesa, Arizona · Not yet recruiting

  • Research Site

    Escondido, California · Recruiting

  • Research Site

    Bridgeport, Connecticut · Not yet recruiting

  • Research Site

    Clearwater, Florida · Recruiting

  • Research Site

    Jacksonville, Florida · Not yet recruiting

  • Research Site

    Stockbridge, Georgia · Recruiting

  • Research Site

    Champaign, Illinois · Recruiting

  • Research Site

    Chicago, Illinois · Recruiting

  • Research Site

    Ames, Iowa · Recruiting

  • Research Site

    El Dorado, Kansas · Not yet recruiting

  • Research Site

    Owensboro, Kentucky · Not yet recruiting

  • Research Site

    Troy, Michigan · Not yet recruiting

  • Research Site

    Jefferson City, Missouri · Not yet recruiting

  • Research Site

    Kansas City, Missouri · Recruiting

  • Research Site

    Butte, Montana · Not yet recruiting

  • Research Site

    Las Vegas, Nevada · Not yet recruiting

  • Research Site

    Jersey City, New Jersey · Not yet recruiting

  • Research Site

    Cortland, New York · Not yet recruiting

  • Research Site

    Rochester, New York · Not yet recruiting

  • Research Site

    Rocky Mount, North Carolina · Recruiting

  • Research Site

    Statesville, North Carolina · Recruiting

  • Research Site

    Wilmington, North Carolina · Not yet recruiting

  • Research Site

    Fargo, North Dakota · Recruiting

  • Research Site

    Columbus, Ohio · Recruiting

  • Research Site

    Maumee, Ohio · Not yet recruiting

  • Research Site

    Tulsa, Oklahoma · Recruiting

  • Research Site

    Portland, Oregon · Not yet recruiting

  • Research Site

    Philadelphia, Pennsylvania · Recruiting

  • Research Site

    Smithfield, Pennsylvania · Recruiting

  • Research Site

    Kingsport, Tennessee · Recruiting

  • Research Site

    Memphis, Tennessee · Not yet recruiting

  • Research Site

    Houston, Texas · Recruiting

  • Research Site

    San Antonio, Texas · Not yet recruiting

  • Research Site

    Sugar Land, Texas · Recruiting

  • Research Site

    Waco, Texas · Recruiting

  • Research Site

    Salt Lake City, Utah · Not yet recruiting

  • Research Site

    Arlington, Virginia · Not yet recruiting

  • Research Site

    Renton, Washington · Withdrawn

Showing 40 of 220 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.